Chatham Capital Group Inc. Sells 1,275 Shares of Proto Labs (PRLB)

Chatham Capital Group Inc. lowered its stake in shares of Proto Labs (NYSE:PRLB) by 7.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,925 shares of the industrial products company’s stock after selling 1,275 shares during the period. Chatham Capital Group Inc. owned 0.06% of Proto Labs worth $1,872,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of PRLB. California Public Employees Retirement System lifted its position in shares of Proto Labs by 131.2% during the third quarter. California Public Employees Retirement System now owns 8,785 shares of the industrial products company’s stock worth $705,000 after acquiring an additional 4,985 shares in the last quarter. Louisiana State Employees Retirement System lifted its position in shares of Proto Labs by 7.0% during the fourth quarter. Louisiana State Employees Retirement System now owns 10,700 shares of the industrial products company’s stock worth $1,102,000 after acquiring an additional 700 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its position in shares of Proto Labs by 7.1% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 118,709 shares of the industrial products company’s stock worth $12,228,000 after acquiring an additional 7,826 shares in the last quarter. Conestoga Capital Advisors LLC lifted its position in shares of Proto Labs by 16.1% during the fourth quarter. Conestoga Capital Advisors LLC now owns 588,419 shares of the industrial products company’s stock worth $60,607,000 after acquiring an additional 81,745 shares in the last quarter. Finally, American Capital Management Inc. raised its position in shares of Proto Labs by 0.4% in the fourth quarter. American Capital Management Inc. now owns 134,634 shares of the industrial products company’s stock worth $13,867,000 after buying an additional 470 shares in the last quarter. Hedge funds and other institutional investors own 97.49% of the company’s stock.

A number of equities research analysts recently issued reports on the company. ValuEngine upgraded Proto Labs from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 2nd. Zacks Investment Research downgraded Proto Labs from a “buy” rating to a “hold” rating in a research report on Wednesday, April 11th. Four analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $98.33.

Shares of PRLB stock opened at $118.60 on Friday. Proto Labs has a 52-week low of $116.65 and a 52-week high of $118.65. The firm has a market capitalization of $3.15 billion, a P/E ratio of 61.45, a price-to-earnings-growth ratio of 2.33 and a beta of 0.96.

Proto Labs (NYSE:PRLB) last issued its quarterly earnings data on Thursday, April 26th. The industrial products company reported $0.71 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.03. Proto Labs had a return on equity of 12.88% and a net margin of 15.49%. The company had revenue of $107.70 million for the quarter, compared to the consensus estimate of $103.88 million. During the same quarter last year, the business posted $0.51 earnings per share. The firm’s revenue was up 34.3% compared to the same quarter last year. analysts expect that Proto Labs will post 2.6 EPS for the current fiscal year.

In related news, Director John B. Goodman sold 1,114 shares of the stock in a transaction on Wednesday, March 14th. The stock was sold at an average price of $122.71, for a total value of $136,698.94. Following the sale, the director now owns 11,091 shares in the company, valued at $1,360,976.61. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.64% of the company’s stock.

Proto Labs Profile

Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce enabled digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets.

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit